Such data can provide valuable insights into the functional roles of cancer cell surface receptors, their interaction partners, and their dysregulation during cancer progression, including primary disease, recurrence, and drug resistance [11,12], paving the way for the development of more effective therapeutics. The gene discussed is CD177; the disease is cancer.